Explore Biotech Companies

Flare Therapeutics, a biotech company, targets transcription factors to develop precision medicines for oncology, with lead programs in urothelial and prostate cancer.

📍 Cambridge, MA

Expedition Medicines uses generative AI and covalent chemistry to discover novel small molecule drugs.

📍 Cambridge, MA

Small molecule drug discovery and development company with pioneering technology to address intractable pharmaceutical targets using its ExoSight™ platform.

📍 Cambridge, MA

Eutropics Pharmaceuticals develops predictive diagnostic tests for cancer, advancing personalized medicine and companion diagnostics.

📍 Cambridge, MA

Etiome uses an AI platform and multiomics data to forecast disease progression and develop preemptive medicines.

📍 Cambridge, MA

Pharma consulting firm providing R&D and manufacturing support for biotech, pharma, and medical device clients, including immunotherapy and polymer development.

📍 Worcester, MA

Empatica, an MIT spin-off, develops AI-enabled wearables and software for continuous health monitoring, specializing in seizure detection and neurological conditions.

📍 Cambridge, MA

eGenesis uses CRISPR for xenotransplantation, developing human-compatible organs to address organ failure and the donor shortage crisis.

📍 Cambridge, MA

Editas Medicine is a clinical-stage biotech company developing transformative CRISPR gene editing therapies for serious diseases, including rare genetic disorders and high cholesterol.

📍 Cambridge, MA

DropGenie automates gene editing with microfluidics for personalized medicine, accelerating discovery from patient cells.

📍 Cambridge, MA

DLRC Group is an award-winning international consultancy supporting Pharma, Biotech, and MedTech companies with regulatory affairs and product development.

📍 Cambridge, MA

Design Pharmaceuticals is a biotech firm specializing in small molecule drug discovery using AI and ultra-high throughput bioscience technologies.

📍 Cambridge, MA

DEM BioPharma is an immuno-oncology company developing cell therapies using the 'Don't Eat Me' signal to unleash the innate immune system against cancer.

📍 Cambridge, MA

Cytel is a leading data-science CRO providing clinical trial design SaaS, biometric services, and advanced analytics for drug development.

📍 King of Prussia, PA

Cullinan Therapeutics is a clinical-stage biopharma company developing oncology and autoimmune disease therapies.

📍 Cambridge, MA

Concerto Biosciences is a clinical-stage biotech company focused on bacterial skin therapies, leveraging a vast microbial interaction dataset to develop innovative products.

📍 Cambridge, MA

ConcertAI is a leader in AI SaaS and real-world data research solutions for oncology, accelerating insights and patient outcomes.

📍 Cambridge, MA

Clear Scientific is a biopharmaceutical company developing small-molecule sequestrants to treat conditions caused by harmful substances in the body.

📍 Cambridge, MA

Cerberus Therapeutics uses alpaca-derived nanobodies to develop novel immunological solutions for autoimmune and infectious diseases.

📍 Cambridge, MA

Casma Therapeutics is a biotech company reprogramming autophagy to develop targeted therapies for various diseases by engaging lysosomal and autophagy systems.

📍 Cambridge, MA

CAMP4 Therapeutics is a clinical-stage biotech company developing first-in-class RNA amplified therapeutics to treat genetic diseases by restoring healthy gene expression.

📍 Cambridge, MA

Breathe BioMedical develops a breath analytics platform for early disease detection, initially focusing on a breath test for breast cancer detection.

📍 Cambridge, MA

Boston Pharmaceuticals acquires and transforms innovative molecules into differentiated medicines, addressing unmet medical needs.

📍 Cambridge, MA

Boston Biotech Clinical Research offers rare disease expertise and clinical-regulatory consulting for biotech and pharma companies, streamlining drug development.

📍 Cambridge, MA